YOLFTbeta
Runben Biotechnology Co Ltd Ordinary Shares - Class A

Runben Biotechnology Co Ltd Ordinary Shares - Class A

603193 · SHG · Consumer Defensive / Household & Personal Products

16.55CNY+0.27 (+1.66%)

Price History

Full chart

Market Stats

Previous Close16.28
Open16.35
Day Range16.21 – 16.93
52-Week Range17.52 – 27.51
Volume4.64M
Market Cap8.19B
P/E (TTM)23.01
Forward P/E0.00
EPS0.88
Dividend Yield2.67%
Beta0.17
50-Day Avg20.71
200-Day Avg22.45

About

Runben Biotechnology Co., Ltd. engages in the research, production, and sale of mosquito repellent products, infant care products, and essential oil products. The company also sells its products through online channels. Runben Biotechnology Co., Ltd. was founded in 1993 and is based in Guangzhou, China.

Company Details

  • SectorConsumer Defensive
  • IndustryHousehold & Personal Products
  • CEOMr. Guiqin Zhao
  • Employees1.02K
  • HeadquartersNo. 3, Xinzhuang 5th Road, Guangzhou, China, 510627, China
  • Websitehttps://www.runben.com

Leadership

  • Mr. Guiqin ZhaoGM & Chairman of the Board · b. 1975
  • Ms. Songjuan BaoDeputy GM & Vice Chairman · b. 1971
  • Mr. Weibin WuCFO & Secretary to the Board · b. 1978
  • Yanjuan YeHead of Accounting

Financials

Income Statement

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue278.64M442.83M582.15M856.09M1.03B1.32B1.54B
Growth (%)-+58.93%+31.46%+47.06%+20.66%+27.61%+17.19%
Cost of Revenue129.71M210.99M275.75M393.28M453.34M553.20M644.04M
Gross Profit148.92M231.83M306.40M462.81M579.62M764.98M900.76M
Gross Margin53.45%52.35%52.63%54.06%56.11%58.03%58.31%
Operating Expense107.23M121.66M165.51M277.01M315.00M417.88M566.90M
Operating Income41.70M110.17M140.89M185.80M264.62M347.10M333.86M
Operating Margin14.96%24.88%24.20%21.70%25.62%26.33%21.61%
EBITDA51.58M118.28M151.25M206.38M288.12M371.76M384.35M
EBITDA Margin18.51%26.71%25.98%24.11%27.89%28.20%24.88%
Net Income35.67M94.71M120.65M160.04M226.03M300.16M314.50M
Net Income Margin12.80%21.39%20.72%18.69%21.88%22.77%20.36%
R&D7.81M10.71M13.60M19.51M25.69M35.07M37.59M
R&D as % of Total Revenue2.80%2.42%2.34%2.28%2.49%2.66%2.43%
Interest Expense1.82M34.59K591.21K1.24M353.46K131.57K81.26K
Interest Expense % of Total Revenue0.65%0.01%0.10%0.14%0.03%0.01%0.01%

Balance Sheet

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets164.43M276.47M646.34M825.42M2.02B2.22B2.34B
Total Liabilities27.07M26.33M84.69M102.83M97.61M138.88M116.79M
Total Equity137.36M250.14M561.65M722.59M1.92B2.08B2.22B
Cash31.12M39.53M206.19M368.21M243.83M106.59M185.77M
Total Debt--10.31M7.91M2.04M1.42M-
Net Debt-31.12M-39.53M-195.88M-360.31M-239.83M-105.17M-

Cash Flow

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow61.91M87.14M138.65M165.32M252.52M257.24M275.26M
Investing Cash Flow-42.32M-74.98M-164.14M9.53M-1.31B-296.92M-
Financing Cash Flow-11.65M16.25M188.39M-9.39M972.84M-137.56M-
Capital Expenditure18.49M58.20M152.03M40.65M13.65M74.22M87.83M
Free Cash Flow43.42M28.93M-13.38M124.67M238.87M183.02M187.42M
Dividends Paid--30.95M3.44M-136.04M176.19M
FCF to OCF70.13%33.20%-9.65%75.41%94.59%71.15%68.09%
Dividend Paid to FCF---231.31%2.76%-74.33%94.01%

Key Statistics & Ratios

Market Cap8.19B
Enterprise Value6.74B
Trailing P/E23.01
Forward P/E0.00
Price / Sales4.81
Price / Book3.52
EPS0.88
Book Value5.79
Revenue (TTM)1.70B
Gross Profit (TTM)1.02B
EBITDA389.28M
Profit Margin20.67%
Operating Margin24.63%
Return on Equity15.59%
Return on Assets9.42%
Shares Outstanding404.59M
Shares Float82.23M
Beta0.17
Dividend Yield2.67%
Dividend Rate0.54
Payout Ratio52.27%

Dividends

20261×
0.26May 29, 2026
20252×
0.20Sep 18, 20250.23May 30, 2025
20242×
0.18Oct 30, 20240.17May 29, 2024